B. Riley Financial Boosts Diversified Healthcare Trust (NASDAQ:DHC) Price Target to $8.50

Diversified Healthcare Trust (NASDAQ:DHC) had its price target boosted by research analysts at B. Riley Financial from $6.50 to $8.50 in a note issued to investors on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the real estate investment trust’s stock. B. Riley Financial’s price target indicates a potential upside of 12.58% from the company’s current price.

A number of other research analysts have also commented on DHC. Zacks Research raised Diversified Healthcare Trust from a “strong sell” rating to a “hold” rating in a report on Friday, February 20th. Royal Bank Of Canada upped their price target on shares of Diversified Healthcare Trust from $5.00 to $6.00 and gave the company a “sector perform” rating in a research note on Monday. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Diversified Healthcare Trust in a research note on Wednesday, January 21st. One research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $7.25.

Diversified Healthcare Trust Stock Performance

Shares of DHC stock opened at $7.55 on Tuesday. Diversified Healthcare Trust has a 52 week low of $2.00 and a 52 week high of $7.61. The company has a market capitalization of $1.83 billion, a price-to-earnings ratio of -6.34 and a beta of 2.39. The company has a 50-day simple moving average of $5.89 and a 200 day simple moving average of $4.91. The company has a debt-to-equity ratio of 1.44, a quick ratio of 2.36 and a current ratio of 2.36.

Diversified Healthcare Trust (NASDAQ:DHC) last issued its quarterly earnings data on Monday, February 23rd. The real estate investment trust reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.21). Diversified Healthcare Trust had a negative return on equity of 15.98% and a negative net margin of 18.59%.The company had revenue of $379.57 million for the quarter, compared to analyst estimates of $392.89 million.

Insider Transactions at Diversified Healthcare Trust

In other news, CEO Christopher J. Bilotto bought 20,000 shares of the firm’s stock in a transaction on Monday, December 15th. The shares were purchased at an average cost of $4.89 per share, with a total value of $97,800.00. Following the acquisition, the chief executive officer directly owned 266,285 shares in the company, valued at $1,302,133.65. This represents a 8.12% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.37% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its stake in Diversified Healthcare Trust by 1.0% during the fourth quarter. Vanguard Group Inc. now owns 19,768,282 shares of the real estate investment trust’s stock worth $95,876,000 after purchasing an additional 205,285 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Diversified Healthcare Trust by 0.8% in the 2nd quarter. Geode Capital Management LLC now owns 5,847,246 shares of the real estate investment trust’s stock valued at $20,936,000 after purchasing an additional 44,759 shares during the last quarter. Charles Schwab Investment Management Inc. raised its holdings in shares of Diversified Healthcare Trust by 13.8% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 5,108,830 shares of the real estate investment trust’s stock worth $24,778,000 after buying an additional 619,750 shares in the last quarter. Carronade Capital Management LP lifted its position in shares of Diversified Healthcare Trust by 4.4% during the 4th quarter. Carronade Capital Management LP now owns 4,763,537 shares of the real estate investment trust’s stock worth $23,103,000 after buying an additional 201,789 shares during the last quarter. Finally, Goldman Sachs Group Inc. lifted its position in shares of Diversified Healthcare Trust by 158.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 3,862,334 shares of the real estate investment trust’s stock worth $9,270,000 after buying an additional 2,370,459 shares during the last quarter. 75.98% of the stock is owned by institutional investors.

Diversified Healthcare Trust Company Profile

Diversified Healthcare Trust is a real estate investment trust (REIT) specializing in the acquisition, ownership and management of healthcare properties across the United States. The company focuses on assets that serve the senior housing and post-acute care sectors, including skilled nursing facilities, assisted living communities, memory care centers and medical office buildings. By partnering with experienced operators, Diversified Healthcare Trust aims to generate stable, long-term cash flows through triple-net leases and percentage rent structures tailored to each property type.

The company’s portfolio spans multiple states and encompasses a mix of single-tenant and multi-tenant properties.